Q32 Bio Inc (QTTB) insider trading

Every open-market stock purchase and sale by Q32 Bio Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Jodie Pope Morrison (CEO) and 2 others sold $320K in the last 90 days.
  • Last insider buy: Orbimed Advisors LLC (10% owner), $10M, 5 months ago.

Last 12 months: insiders bought $30M (2 buys) and sold $505K (11 sales). Last close $8.80 on Oct 22, 2026.

Recent QTTB insider trades

DateInsiderTradeValue
Oct 6, 2026Jodie Pope Morrison (CEO)Sold$26.8K
Oct 6, 2026Lee Kalowski (CFO)Sold$10.8K
Oct 6, 2026Shelia M. Violette (C-suite exec)Sold$7.6K
Aug 25, 2026Jodie Pope Morrison (CEO)Sold$163K
Aug 25, 2026Lee Kalowski (CFO)Sold$65.8K
Aug 25, 2026Shelia M. Violette (C-suite exec)Sold$46.3K
Jul 16, 2026Shelia M. Violette (C-suite exec)Bought (not open market)—
Jul 16, 2026Jodie Pope Morrison (CEO)Bought (not open market)—
Jul 16, 2026Lee Kalowski (CFO)Bought (not open market)—
Jun 30, 2026Isaac Manke (Insider)Bought (not open market)$150K
Jun 30, 2026Isaac Manke (Insider)Bought (not open market)—
Jun 12, 2026Diyong Xu (Insider)Bought (not open market)—
Jun 12, 2026Mark T Iwicki (Insider)Bought (not open market)—
Jun 12, 2026David S. Grayzel (Insider)Bought (not open market)—
Jun 12, 2026Isaac Manke (Insider)Bought (not open market)—
Jun 12, 2026Mary Thistle (Insider)Bought (not open market)—
Jun 12, 2026Mary Thistle (Insider)Bought (not open market)—
Jun 12, 2026David S. Grayzel (Insider)Bought (not open market)—
Jun 12, 2026Mark T Iwicki (Insider)Bought (not open market)—
Jun 12, 2026Kathleen Laporte (Insider)Bought (not open market)—
Jun 12, 2026Sven Ante Lundberg (Insider)Bought (not open market)—
Jun 12, 2026Isaac Manke (Insider)Bought (not open market)—
Jun 12, 2026Diyong Xu (Insider)Bought (not open market)—
Jun 12, 2026Arthur Tzianabos (Insider)Bought (not open market)—
Jun 12, 2026Arthur Tzianabos (Insider)Bought (not open market)—

Who's trading QTTB

Get free alerts when an insider at Q32 Bio Inc files a new trade →